3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide

C101H89F9N20O8 — CID 172957479

IUPAC3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
SMILESCN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)[nH]2)cc1.CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(C)c(C(F)(F)F)c3)c(F)c2)ccn1.Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1.Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(C)(F)F)[nH]4)c3)ccc21
InChIInChI=1S/C27H27N5O2.C27H25N5O2.C25H19F5N6O.C22H18F4N4O3/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33;1-17-8-9-21(31-25(33)18-6-5-7-19(12-18)27(2,3)15-28)14-24(17)30-20-10-11-23-22(13-20)26(34)32(4)16-29-23;1-24(26,27)21-13-32-22(35-21)19-12-17(9-10-31-19)37-16-7-8-20-18(11-16)34-23(36(20)2)33-15-5-3-14(4-6-15)25(28,29)30;1-12-3-4-13(9-16(12)22(24,25)26)29-21(32)30-18-6-5-14(10-17(18)23)33-15-7-8-28-19(11-15)20(31)27-2/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30);5-14,16,30H,1-4H3,(H,31,33);3-13H,1-2H3,(H,32,35)(H,33,34);3-11H,1-2H3,(H,27,31)(H2,29,30,32)/b31-24+;;;
InChIKeyCHVWMOOYFJFKDE-WDYDTJNOSA-N
MW1881.94 g/mol
LogP22.28
Rot. Bonds23

About 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide

3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide (PubChem CID 172957479) has the molecular formula C101H89F9N20O8 and a molecular weight of 1881.94 g/mol. Its IUPAC name is 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide.

Molecular Properties

Compound Name3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
PubChem CID172957479
Molecular FormulaC101H89F9N20O8
Molecular Weight1881.94 g/mol
Exact Mass1880.70
IUPAC Name3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
SMILESCN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)[nH]2)cc1.CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(C)c(C(F)(F)F)c3)c(F)c2)ccn1.Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1.Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(C)(F)F)[nH]4)c3)ccc21
InChIInChI=1S/C27H27N5O2.C27H25N5O2.C25H19F5N6O.C22H18F4N4O3/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33;1-17-8-9-21(31-25(33)18-6-5-7-19(12-18)27(2,3)15-28)14-24(17)30-20-10-11-23-22(13-20)26(34)32(4)16-29-23;1-24(26,27)21-13-32-22(35-21)19-12-17(9-10-31-19)37-16-7-8-20-18(11-16)34-23(36(20)2)33-15-5-3-14(4-6-15)25(28,29)30;1-12-3-4-13(9-16(12)22(24,25)26)29-21(32)30-18-6-5-14(10-17(18)23)33-15-7-8-28-19(11-15)20(31)27-2/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30);5-14,16,30H,1-4H3,(H,31,33);3-13H,1-2H3,(H,32,35)(H,33,34);3-11H,1-2H3,(H,27,31)(H2,29,30,32)/b31-24+;;;
InChIKeyCHVWMOOYFJFKDE-WDYDTJNOSA-N
XLogP22.28
TPSA359.44 Ų
H-Bond Donors9
H-Bond Acceptors22
Rotatable Bonds23
Heavy Atoms138
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001881.94
LogP ≤ 522.28
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide?
The IUPAC name of 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide (CID 172957479) is 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide.
What is the SMILES notation for 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide?
The canonical SMILES for 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide is CN(C)CCOc1ccc(-c2nc(-c3ccc4c(c3)CC/C4=N\O)c(-c3ccncc3)[nH]2)cc1.CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(C)c(C(F)(F)F)c3)c(F)c2)ccn1.Cc1ccc(NC(=O)c2cccc(C(C)(C)C#N)c2)cc1Nc1ccc2ncn(C)c(=O)c2c1.Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(C)(F)F)[nH]4)c3)ccc21.
What is the InChIKey of 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide?
The InChIKey is CHVWMOOYFJFKDE-WDYDTJNOSA-N. The full InChI is InChI=1S/C27H27N5O2.C27H25N5O2.C25H19F5N6O.C22H18F4N4O3/c1-32(2)15-16-34-22-7-3-19(4-8-22)27-29-25(18-11-13-28-14-12-18)26(30-27)21-5-9-23-20(17-21)6-10-24(23)31-33;1-17-8-9-21(31-25(33)18-6-5-7-19(12-18)27(2,3)15-28)14-24(17)30-20-10-11-23-22(13-20)26(34)32(4)16-29-23;1-24(26,27)21-13-32-22(35-21)19-12-17(9-10-31-19)37-16-7-8-20-18(11-16)34-23(36(20)2)33-15-5-3-14(4-6-15)25(28,29)30;1-12-3-4-13(9-16(12)22(24,25)26)29-21(32)30-18-6-5-14(10-17(18)23)33-15-7-8-28-19(11-15)20(31)27-2/h3-5,7-9,11-14,17,33H,6,10,15-16H2,1-2H3,(H,29,30);5-14,16,30H,1-4H3,(H,31,33);3-13H,1-2H3,(H,32,35)(H,33,34);3-11H,1-2H3,(H,27,31)(H2,29,30,32)/b31-24+;;;.
What are the key properties of 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide?
3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide has a molecular weight of 1881.94 g/mol, XLogP of 22.28, 23 rotatable bonds, 9 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxoquinazolin-6-yl)amino]phenyl]benzamide;5-[[2-[5-(1,1-difluoroethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-1-methyl-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine;(NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine;4-[3-fluoro-4-[[4-methyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide is sourced from PubChem (CID 172957479), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).